MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-DL-06-0012675
Ishir Pharmaceuticals Private Limited
Ishir Pharmaceuticals Private Limited - chemicals and materials in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹12,000
▲ 76% YoY
Net loss · FY 2023
₹6,190
Net margin -51.6%
EBITDA · FY 2023
-₹6,190
EBITDA margin -51.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹5,000
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Ishir Pharmaceuticals Private Limited
Data last updated:
Ishir Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 21 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52609DL2020PTC373511. Its GSTIN is 07AAFCI9078N1ZS (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹5,000. It is led by directors Ishwar Mittal Chand and Sudesh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No.69 Old – Wz – 173/69 Block – Wz Landmark Na Siri Nagar Shakur Basti, New Delhi, Delhi, India – 110034.
As per the financials filed for FY 2023, the company reported a revenue of ₹12,000, a growth of 76% compared to the previous year. For the same year it recorded a net loss of ₹6,190 (net margin -51.6%) and EBITDA of -₹6,190 (EBITDA margin -51.6%).
Ishir Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0012675).
Company details
CIN U52609DL2020PTC373511
Registration Number 373511
Incorporation Date 21 November 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-06-0012675
Key People
Ishwar Mittal Chand Director Sudesh Director Recognitions & Rankings of Ishir Pharmaceuticals
Contact details
Ishir Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No.69 Old – Wz – 173/69 Block – Wz Landmark Na Siri Nagar Shakur Basti, New Delhi, Delhi, India – 110034
- IndustryChemicals and Materials, Chemical Distribution & Retail
To see the full contact details of Ishir Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Ishir Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Ishir Pharmaceuticals is professional, scientific and technical activities. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 74 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Ishir Pharmaceuticals Private Limited, buy the company report.
Financials of Ishir Pharmaceuticals Private Limited
FY 2025 filings availableIshir Pharmaceuticals Private Limited reported revenue of ₹12,000 (up 76% YoY) for FY 2023.
Revenue · FY 2023
₹12,000 ▲ 76%
Net loss · FY 2023
₹6,190 margin -51.6%
EBITDA · FY 2023
-₹6,190 margin -51.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 76%
EBITDA CAGR growth
1 year
▲ 66%
Revenue rose 76% in the latest year. EBITDA rose 66% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹6,190 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹6,190 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -51.6% | ||
| Net Profit Margin | -51.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Ishir Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ishir Pharmaceuticals Private Limited
Ishir Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ishwar Mittal Chand | Director | 21 Nov 2020 | 5 Years 11 Months | Current |
| Sudesh | Director | 21 Nov 2020 | 5 Years 11 Months | Current |
Auditor
Ishir Pharmaceuticals Private Limited is audited by MISHRA S & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MISHRA S & CO | FY 2021 | 030764N |
Shareholding
The shareholding of Ishir Pharmaceuticals Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Ishir Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ishir Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ishir Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ishir Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
Active EPFO establishments
1
GST
Ishir Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCI9078N1ZS | Delhi | Active | 18 Dec 2020 |
To see the full GST registrations and return filing status of Ishir Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ishir Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Ishwar Mittal Chand was appointed as Director on 21 Nov 2020.
AGM
Ishir Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ishir Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Appointed
Ishwar Mittal Chand was appointed as Director.
Appointed
Sudesh was appointed as Director.
Incorporation
21 Nov 2020
Ishir Pharmaceuticals Private Limited was registered on 21 Nov 2020 with Roc Delhi Ii & aged 5 years 11 months as per MCA records.
Frequently asked questions
Ishir Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 21 November 2020 (6+ years old) and is registered under CIN U52609DL2020PTC373511.
Ishir Pharmaceuticals has 2 current directors:
- Ishwar Mittal Chand - Director
- Sudesh - Director
The latest financial statements of Ishir Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Ishir Pharmaceuticals is 07AAFCI9078N1ZS, registered in Delhi.
The CIN (Corporate Identification Number) of Ishir Pharmaceuticals is U52609DL2020PTC373511. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ishir Pharmaceuticals was incorporated on 21 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Ishwar Mittal Chand was appointed as Director on 21 Nov 2020. Sudesh was appointed as Director on 21 Nov 2020.
Yes, Ishir Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-06-0012675).
The registered office of Ishir Pharmaceuticals is at House No.69 Old – Wz – 17369 Block – Wz Landmark Na Siri Nagar Shakur Basti, New Delhi, Delhi, India – 110034.
Ishir Pharmaceuticals operates in the chemicals and materials industry, in the chemical distribution and retail segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages